Discordance of Estrogen Receptor Status Between Primary and Metastatic Breast Cancer: Possible Reasons and Prognostic Value
The aim of the review was systematization of the data on discordance in expression of estrogen receptors between primary and metastatic breast cancer, different metastases and repeated analyses of the same tissue. The possible reasons for the phenomenon are discussed. The authors emphasize the need...
Saved in:
| Main Authors: | T. A. Bogush, A. S. Popova, E. A. Dudko, E. O. Ignatova, B. E. Polotsky, S. A. Tjuljandin, M. I. Davydov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/500 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estrogen Receptor Expression in Tumors Different from Breast Cancer
by: T. A. Bogush, et al.
Published: (2020-05-01) -
Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2− advanced or metastatic breast cancer: phase 1/2 study results
by: Erika P. Hamilton, et al.
Published: (2025-07-01) -
Features of Breast Cancer Progression after Comprehensive Treatment, Prognosis of Metastatic Spread
by: Yu. Chuprovska, et al.
Published: (2025-06-01) -
Comprehensive mapping elucidates high risk genotypes in primary metastatic breast cancer
by: Tobias Berg, et al.
Published: (2025-05-01) -
MODERN POSSIBILITIES OF APPLICATION OF PREPARATION NAVELBINE® IN THE TREATMENT OF METASTATIC BREAST CANCER
by: L. V. Bolotina
Published: (2016-06-01)